| pubmed-article:19887466 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19887466 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:19887466 | lifeskim:mentions | umls-concept:C0151313 | lld:lifeskim |
| pubmed-article:19887466 | lifeskim:mentions | umls-concept:C1527249 | lld:lifeskim |
| pubmed-article:19887466 | lifeskim:mentions | umls-concept:C0015219 | lld:lifeskim |
| pubmed-article:19887466 | lifeskim:mentions | umls-concept:C0282461 | lld:lifeskim |
| pubmed-article:19887466 | lifeskim:mentions | umls-concept:C0021149 | lld:lifeskim |
| pubmed-article:19887466 | lifeskim:mentions | umls-concept:C0936012 | lld:lifeskim |
| pubmed-article:19887466 | lifeskim:mentions | umls-concept:C2349200 | lld:lifeskim |
| pubmed-article:19887466 | lifeskim:mentions | umls-concept:C1709595 | lld:lifeskim |
| pubmed-article:19887466 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:19887466 | pubmed:dateCreated | 2010-3-26 | lld:pubmed |
| pubmed-article:19887466 | pubmed:abstractText | The purpose of this study was to determine whether the presence of diabetes mellitus (DM) influences the incidence, severity, and/or course of peripheral sensory neuropathy (PSN) after oxaliplatin (FOLFOX) therapy in patients with colorectal cancer (CRC). | lld:pubmed |
| pubmed-article:19887466 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19887466 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19887466 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19887466 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19887466 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19887466 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19887466 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19887466 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:19887466 | pubmed:issn | 1569-8041 | lld:pubmed |
| pubmed-article:19887466 | pubmed:author | pubmed-author:GuptaSS | lld:pubmed |
| pubmed-article:19887466 | pubmed:author | pubmed-author:GoldbergR MRM | lld:pubmed |
| pubmed-article:19887466 | pubmed:author | pubmed-author:de GramontAA | lld:pubmed |
| pubmed-article:19887466 | pubmed:author | pubmed-author:RothenbergM... | lld:pubmed |
| pubmed-article:19887466 | pubmed:author | pubmed-author:AndréTT | lld:pubmed |
| pubmed-article:19887466 | pubmed:author | pubmed-author:TournigandCC | lld:pubmed |
| pubmed-article:19887466 | pubmed:author | pubmed-author:RamanathanR... | lld:pubmed |
| pubmed-article:19887466 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19887466 | pubmed:volume | 21 | lld:pubmed |
| pubmed-article:19887466 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19887466 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19887466 | pubmed:pagination | 754-8 | lld:pubmed |
| pubmed-article:19887466 | pubmed:meshHeading | pubmed-meshheading:19887466... | lld:pubmed |
| pubmed-article:19887466 | pubmed:meshHeading | pubmed-meshheading:19887466... | lld:pubmed |
| pubmed-article:19887466 | pubmed:meshHeading | pubmed-meshheading:19887466... | lld:pubmed |
| pubmed-article:19887466 | pubmed:meshHeading | pubmed-meshheading:19887466... | lld:pubmed |
| pubmed-article:19887466 | pubmed:meshHeading | pubmed-meshheading:19887466... | lld:pubmed |
| pubmed-article:19887466 | pubmed:meshHeading | pubmed-meshheading:19887466... | lld:pubmed |
| pubmed-article:19887466 | pubmed:meshHeading | pubmed-meshheading:19887466... | lld:pubmed |
| pubmed-article:19887466 | pubmed:meshHeading | pubmed-meshheading:19887466... | lld:pubmed |
| pubmed-article:19887466 | pubmed:meshHeading | pubmed-meshheading:19887466... | lld:pubmed |
| pubmed-article:19887466 | pubmed:meshHeading | pubmed-meshheading:19887466... | lld:pubmed |
| pubmed-article:19887466 | pubmed:meshHeading | pubmed-meshheading:19887466... | lld:pubmed |
| pubmed-article:19887466 | pubmed:meshHeading | pubmed-meshheading:19887466... | lld:pubmed |
| pubmed-article:19887466 | pubmed:meshHeading | pubmed-meshheading:19887466... | lld:pubmed |
| pubmed-article:19887466 | pubmed:meshHeading | pubmed-meshheading:19887466... | lld:pubmed |
| pubmed-article:19887466 | pubmed:meshHeading | pubmed-meshheading:19887466... | lld:pubmed |
| pubmed-article:19887466 | pubmed:meshHeading | pubmed-meshheading:19887466... | lld:pubmed |
| pubmed-article:19887466 | pubmed:meshHeading | pubmed-meshheading:19887466... | lld:pubmed |
| pubmed-article:19887466 | pubmed:meshHeading | pubmed-meshheading:19887466... | lld:pubmed |
| pubmed-article:19887466 | pubmed:meshHeading | pubmed-meshheading:19887466... | lld:pubmed |
| pubmed-article:19887466 | pubmed:meshHeading | pubmed-meshheading:19887466... | lld:pubmed |
| pubmed-article:19887466 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:19887466 | pubmed:articleTitle | Incidence and evolution of oxaliplatin-induced peripheral sensory neuropathy in diabetic patients with colorectal cancer: a pooled analysis of three phase III studies. | lld:pubmed |
| pubmed-article:19887466 | pubmed:affiliation | TGen Clinical Research Services at Scottsdale Healthcare, 13208 East Shea Boulevard, Scottsdale, AZ 85259, USA. rramanathan@tgen.org | lld:pubmed |
| pubmed-article:19887466 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19887466 | pubmed:publicationType | Meta-Analysis | lld:pubmed |
